Advancing Cell Therapies for Coronary Microvascular Dysfunction: Experts Roundtable

This live event will address pioneering advancements of cell therapies in select cardiovascular diseases, including in patients with CMD.

Live Meeting
2.00 available credits
Information
November 16, 2019
06:30 PM - 09:00 PM EST
The Ritz-Carlton, Philadelphia
Petite Ballroom 2nd Floor, Ten Avenue of the Arts, Philadelphia, Pennsylvania, United States
Advancing Cell Therapies for Coronary Microvascular Dysfunction: Experts Roundtable
Choose a format
Details
Presenters
Comments
  • Overview

    This innovative, town hall format will address pioneering advancements of cell therapies in select cardiovascular diseases, including coronary microvascular dysfunction (CMD).

    Participants will be provided the opportunity to engage with the expert panelists in a unique learning exchange that promises to lead to improved retention of the clinical practice strategies with the goal of measurably improving health outcomes in cardiology/interventional practice.

    This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the underlying pathophysiology of stable angina
    • Describe appropriate diagnostic studies in the assessment of stable angina
    • Describe the effectiveness and limitations of current therapies for stable angina including PCI and pharmacotherapy                  
  • Program Schedule

    6:30 PM Registration

    7:00 PM Buffet Dinner and Program Overview
    Michael Gibson, MD, Chair and Peter Stone, MD, Co-Chair

    7:05 PM Stable Angina: State of the Art
    Peter Stone, MD

    7:15 PM Microvascular Disease: Prevalence and Unmet Needs
    C. Noel Bairey Merz, MD

    7:30 PM
    Defining Refractory Angina: Epicardial and Microvascular
    Amir Lerman, MD

    7:55 PM Pioneering Advancements in Cell Therapies
    Thomas Povsic, MD

    8:15 PM The Future of Cell-Based Therapies
    Andres Zeiher, MD

    8:35 PM Experts Take!
    All Faculty

    8:50 PM Question and Answer
    All Faculty

    9:00 PM Adjourn

  • Target Audience

    This activity is designed to meet the educational needs of cardiovascular healthcare professionals including physicians, nurses, and pharmacists who manage patients with ischemic cardiovascular disease.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from Caladrius Biosciences.

  • Provider(s)/Educational Partner(s)

    Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Jessica McGrory prior to the live event at jmcgrory@omnia-prova.com.

Facebook Comments

Details
Presenters
Comments
  • Overview

    This innovative, town hall format will address pioneering advancements of cell therapies in select cardiovascular diseases, including coronary microvascular dysfunction (CMD).

    Participants will be provided the opportunity to engage with the expert panelists in a unique learning exchange that promises to lead to improved retention of the clinical practice strategies with the goal of measurably improving health outcomes in cardiology/interventional practice.

    This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the underlying pathophysiology of stable angina
    • Describe appropriate diagnostic studies in the assessment of stable angina
    • Describe the effectiveness and limitations of current therapies for stable angina including PCI and pharmacotherapy                  
  • Program Schedule

    6:30 PM Registration

    7:00 PM Buffet Dinner and Program Overview
    Michael Gibson, MD, Chair and Peter Stone, MD, Co-Chair

    7:05 PM Stable Angina: State of the Art
    Peter Stone, MD

    7:15 PM Microvascular Disease: Prevalence and Unmet Needs
    C. Noel Bairey Merz, MD

    7:30 PM
    Defining Refractory Angina: Epicardial and Microvascular
    Amir Lerman, MD

    7:55 PM Pioneering Advancements in Cell Therapies
    Thomas Povsic, MD

    8:15 PM The Future of Cell-Based Therapies
    Andres Zeiher, MD

    8:35 PM Experts Take!
    All Faculty

    8:50 PM Question and Answer
    All Faculty

    9:00 PM Adjourn

  • Target Audience

    This activity is designed to meet the educational needs of cardiovascular healthcare professionals including physicians, nurses, and pharmacists who manage patients with ischemic cardiovascular disease.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from Caladrius Biosciences.

  • Provider(s)/Educational Partner(s)

    Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Jessica McGrory prior to the live event at jmcgrory@omnia-prova.com.

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free